Interactions between zidovudine and Infergen (interferon alfacon-1)
zidovudine and interferon alfacon-1 (Major Drug-Drug)
MANAGEMENT: Caution is advised if concomitant therapy is necessary, particularly with the alfa interferons. Complete blood counts, differential and platelet counts should be performed regularly and drug dosages adjusted accordingly. Patients should be advised to promptly report symptoms such as chills, fever, sore throat, pale skin, or unusual fatigue to their physician. Cessation of one or all drugs may be necessary if toxicity develops.





